PSMA617-TCMC TFA
PSMA617-TCMC is a structural analog of the theranostic ligand PSMA-617, where the DOTA chelator is replaced by a TCMC macrocycle. This modification is investigated in preclinical research for developing targeted radioligand therapies, with studies focusing on its chelation properties for radiometals in prostate cancer models.
Product Specifications
CAS Number
2937423-47-5
Field of Research
Immunology & Inflammation
Smiles
O=C (O) CC[C@@H] (C (O) =O) NC (N[C@H] (C (O) =O) CCCCNC ([C@@H] (NC ([C@H]1CC[C@H] (CNC (NC2=CC=C (CC3N (CC (N) =O) CCN (CC (N) =O) CCN (CC (N) =O) CCN (CC (N) =O) C3) C=C2) =S) CC1) =O) CC4=CC=C5C=CC=CC5=C4) =O) =O.O=C (O) C (F) (F) F.O=C (O) C (F) (F) F.O=C (O) C (F) (F) F.O=C (O) C (F) (F) F
Molecular Formula
C65H86F12N14O21S
Molecular Weight
1659.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog